Athanasios Tsiatis
Chief Tech/Sci/R&D Officer at ALX ONCOLOGY HOLDINGS INC.
Profile
Athanasios Tsiatis is currently the Senior Vice President-Clinical Development at ALX Oncology Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Plexxikon, Inc. from 2018 to 2021.
He completed his undergraduate degree at New York University and obtained his doctorate from Vanderbilt University School of Medicine.
Athanasios Tsiatis active positions
| Companies | Position | Start |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 31/10/2021 |
Former positions of Athanasios Tsiatis
| Companies | Position | End |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Chief Tech/Sci/R&D Officer | 31/10/2021 |
Training of Athanasios Tsiatis
| New York University | Undergraduate Degree |
| Vanderbilt University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
- Stock Market
- Insiders
- Athanasios Tsiatis
